GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Float Percentage Of Total Shares Outstanding

PixarBio (PixarBio) Float Percentage Of Total Shares Outstanding : 2.09% (As of Jun. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PixarBio's float shares is 1.68 Mil. PixarBio's total shares outstanding is 80.21 Mil. PixarBio's float percentage of total shares outstanding is 2.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PixarBio's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PixarBio's Institutional Ownership is 0.00%.

PixarBio Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

PixarBio's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=1.68/80.21
=2.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PixarBio (PixarBio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
VSAR ARCT ASX:ZLD TSXV:ATE ASX:ANR XPAR:OSE NTRP OSL:HBC XKRX:216400 LSE:HVO OSTO:ACTI BCLI LSE:SCLP ROCO:6580 ASX:BOT LSE:RLM NBY ASX:AHZ NAVB SPHS
Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
Website
https://www.pixarbio.com
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines